TERRAMYCIN Returns to U.S. Veterinary Practices

TERRAMYCIN Returns to U.S. Veterinary Practices

Trusted brand offers safe and effective relief for ocular infections without steroids

FLORHAM PARK, NJ, October 1, 2014 – Zoetis Inc. today announced that TERRAMYCIN® (oxytetracycline hydrochloride) Ophthalmic Ointment with Polymyxin B Sulfate is once again available to veterinarians nationwide. TERRAMYCIN is indicated for the treatment of superficial ocular infection and bacterial inflammatory conditions in dogs and cats.

"Veterinarians trust TERRAMYCIN because of its broad spectrum coverage and the synergistic effects of its active ingredients making it highly effective in treating infections," said J. Michael McFarland, DVM, DABVP and group director of Companion Animal Veterinary Operations for Zoetis. "We are pleased to make TERRAMYCIN available to practices that have relied on it for many years."

TERRAMYCIN is a topical antibiotic, not a steroid, used for safe and effective treatment of superficial ocular infections including conjunctivitis, keratitis, pink eye, corneal ulcer, and bacterial inflammatory conditions. It offers broad-spectrum effectiveness against both Gram-positive and Gram-negative organism, including Pseudomonas aeruginosa.

For more information on TERRAMYCIN go to: https://www.zoetisus.com/products/cats/terramycin-ophthalmic-ointment.aspx

IMPORTANT SAFETY INFORMATION
Discontinue treatment if severe allergic reaction occurs.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenues of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 27 manufacturing facilities in 10 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries.  For more information, visit www.zoetis.com.
 
Zoetis is the proud sponsor, with the Smithsonian Institution Traveling Exhibitions, the American Veterinary Medical Association, and the American Veterinary Medical Foundation, of the mobile educational exhibit Animal Connections: Our Journey Together.  Families visiting the exhibit will explore the vast bonds between people and animals and learn about the important role veterinarians play in protecting animal and human health.  For more information, visit https://www.zoetis.com/animal-connections-tour/.

For further information, Contact:
    
Colleen White
Zoetis  
973-822-7203    
[email protected]     

Julie Lux
archer>malmo
901-500-7063
[email protected]

 

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…